Professor John Thompson

Professor
Surgery, Central Clinical School

T: +61 2 9911 7366
F: +61 2 9954 9435
E:

W: Related website

Research interests

melanoma, skin cancer

Current national competitive grants*

2011

Whole Brain Radiotherapy following local treatment of intracranial metastases of melanoma - a randomised phase III trial
Fogarty G, Burmeister B, Drummond K, Thompson J, Hong A
Cancer Australia Priority-driven Collaborative Cancer Research Scheme ($591,010 over 2 years)

Molecular determinants of risk, progression and treatment response in melanoma
Kefford R, Thompson J, Hersey P, Mann G, Scolyer R, Hayward N
NHMRC Program Grant ($12,065,000 over 5 years)

* Grants administered through the University of Sydney

Keywords

Melanoma and skin cancer; Surgery

Publications

2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008

2014

   
  • Shashank, A., Shehata, M., Morris, D., Thompson, J. (2014), Radiofrequency ablation in metastatic melanoma. Journal of Surgical Oncology. 109(4), 366-369. [Abstract]
  • Kroon, H., Huismans, A., Waugh, R., Kam, P., Thompson, J. (2014), Isolated limb infusion: Technical aspects. Journal of Surgical Oncology. 109(4), 352-356. [Abstract]
  • Menzies, A., Lum, T., Wilmott, J., Hyman, J., Kefford, R., Thompson, J., O'Toole, S., Long, G., Scolyer, R. (2014), Intrapatient Homogeneity of BRAFV600E Expression in Melanoma. The American Journal of Surgical Pathology. 38(3), 377-382. [Abstract]
  • Zimmer, L., Haydu, L., Menzies, A., Scolyer, R., Kefford, R., Thompson, J., Schadendorf, D., Long, G. (2014), Incidence of New Primary Melanomas After Diagnosis of Stage III and IV Melanoma. Journal of Clinical Oncology. 32(8), 816-823. [Abstract]
  • Howman-Giles, R., Uren, R., Thompson, J. (2014), Sentinel Lymph Node Biopsy in Pediatric and Adolescent Patients: A Proven Technique. Annals of Surgery. , e86. [Abstract]
  • Spillane, A., Pasquali, S., Haydu, L., Thompson, J. (2014), Patterns of recurrence and survival after lymphadenectomy in melanoma patients: clarifying the effects of timing of surgery and lymph node tumor burden. Annals of Surgical Oncology. 21(1), 292-299. [Abstract]
  • Marzese, D., Scolyer, R., Huynh, J., Huang, S., Hirose, H., Chong, K., Kiyohara, E., Wang, J., Kawas, N., Donovan, N., Hata, K., Wilmott, J., Murali, R., Buckland, M., Shivalingam, B., Thompson, J., Morton, D., Kelly, D., Hoon, D. (2014), Epigenome-wide DNA methylation landscape of melanoma progression to brain metastasis reveals aberrations on homeobox D cluster associated with prognosis. Human Molecular Genetics. 23(1), 226-238. [Abstract]
  • Fogarty, G., Hong, A., Scolyer, R., Lin, E., Haydu, L., Guitera, P., Thompson, J. (2014), Radiotherapy for lentigo maligna - a literature review and recommendations for treatment. The British Journal of Dermatology. 170(1), 52-58. [Abstract]
  • Thompson, J., Faries, M., Cochran, A. (2014), Sentinel Lymph Node Biopsy for Melanoma: A Plea to Let the Data be Heard. Annals of Surgical Oncology. 21, 3362-2264. [Abstract]
  • Carlino, M., Haydu, L., Kakavand, H., Menzies, A., Hamilton, A., Yu, B., Ng, C., Cooper, W., Thompson, J., Kefford, R., O'Toole, S., Scolyer, R., Long, G. (2014), Correlation of BRAF and NRAS mutation status with outcome, site of distant metastasis and response to chemotherapy in metastatic melanoma. British Journal of Cancer. 111(2), 292-299. [Abstract]
  • Grey, A., Cooper, A., McNeil, C., O'Toole, S., Thompson, J., Grimison, P. (2014), Progression of KRAS mutant pancreatic adenocarcinoma during vemurafenib treatment in a patient with metastatic melanoma. Internal Medicine Journal. 44(6), 597-600. [Abstract]
  • Wiener, M., Uren, R., Thompson, J. (2014), Lymphatic drainage patterns from primary cutaneous tumours of the forehead: Refining the recommendations for selective neck dissection. Journal of Plastic, Reconstructive & Aesthetic Surgery. 67(8), 1038-1044. [Abstract]
  • van der Ploeg, A., Haydu, L., Spillane, A., Scolyer, R., Quinn, M., Saw, R., Shannon, K., Stretch, J., Thompson, J. (2014), Melanoma Patients with an Unknown Primary Tumor Site Have a Better Outcome than Those with a Known Primary Following Therapeutic Lymph Node Dissection for Macroscopic (Clinically Palpable) Nodal Disease. Annals of Surgical Oncology. 21(9), 3108-3116. [Abstract]
  • Suttie, C., Hruby, G., Horvath, L., Thompson, J. (2014), Cardiac metastasis in merkel cell carcinoma. Journal of Clinical Oncology. 32(13), e52-53. [Abstract]
  • Thompson, J., Hruby, G. (2014), The role of sentinel lymph node biopsy in patients with merkel cell carcinoma: uncertainty prevails. Annals of Surgical Oncology. 21, 1517-1519. [Abstract]
  • Naehrig, D., Uren, R., Emmett, L., Ioannou, K., Hong, A., Wratten, C., Thompson, J., Hruby, G. (2014), Sentinel lymph node mapping for defining site and extent of elective radiotherapy management of regional nodes in Merkel cell carcinoma: a pilot case series. Journal of Medical Imaging and Radiation Oncology. 58, 353-359. [Abstract]
  • Niebling, M., Haydu, L., Karim, R., Thompson, J., Scolyer, R. (2014), Pathology Review Significantly Affects Diagnosis and Treatment of Melanoma Patients: An Analysis of 5011 Patients Treated at a Melanoma Treatment Center. Annals of Surgical Oncology. 21, 2245¿2251. [Abstract]
  • Kakavand, H., Crainic, O., Lum, T., O'Toole, S., Kefford, R., Thompson, J., Wilmott, J., Long, G., Scolyer, R. (2014), Concordant BRAFV600E mutation status in primary melanomas and associated naevi: implications for mutation testing of primary melanomas. Pathology. 46(3), 193-198. [Abstract]
  • Rizos, H., Menzies, A., Pupo, G., Carlino, M., Fung, C., Hyman, J., Haydu, L., Mijatov, B., Becker, T., Boyd, S., Howle, J., Saw, R., Thompson, J., Kefford, R., Scolyer, R., Long, G. (2014), BRAF inhibitor resistance mechanisms in metastatic melanoma: spectrum and clinical impact. Clinical Cancer Research. 20(7), 1965-1977. [Abstract]
  • van der Ploeg, A., Haydu, L., Spillane, A., Quinn, M., Saw, R., Shannon, K., Stretch, J., Uren, R., Scolyer, R., Thompson, J. (2014), Outcome Following Sentinel Node Biopsy Plus Wide Local Excision Versus Wide Local Excision Only for Primary Cutaneous Melanoma: Analysis of 5840 Patients Treated at a Single Institution. Annals of Surgery. 260(1), 149-157. [Abstract]
  • Thompson, J. (2014), Local and regional therapies for melanoma: many arrows in the quiver. Journal of Surgical Oncology. 109, 295. [Abstract]
  • Damian, D., Saw, R., Thompson, J. (2014), Topical immunotherapy with diphencyprone for in transit and cutaneously metastatic melanoma. Journal of Surgical Oncology. 109(4), 308-313. [Abstract]
  • Morton, D., Thompson, J., Cochran, A., Mozzillo, N., Nieweg, O., Roses, D., Hoekstra, H., Karakousis, C., Puleo, C., Coventry, B., Kashani-Sabet, M., Smithers, B., Paul, E., Kraybill, W., McKinnon, J., Wang, H., Elashoff, R., Faries, M. (2014), Final trial report of sentinel-node biopsy versus nodal observation in melanoma. The New England Journal of Medicine. 370(7), 599-609. [Abstract]
  • Griewank, K., van de Nes, J., Schilling, B., Moll, I., Sucker, A., Kakavand, H., Haydu, L., Asher, M., Zimmer, L., Hillen, U., Thompson, J., Scolyer, R., Schadendorf, D., Murali, R. (2014), Genetic and clinico-pathologic analysis of metastatic uveal melanoma. Modern Pathology. 27(2), 175-183. [Abstract]
  • Griewank, K., Scolyer, R., Thompson, J., Flaherty, K., Schadendorf, D., Murali, R. (2014), Genetic alterations and personalized medicine in melanoma: progress and future prospects. Journal of the National Cancer Institute. 106(2), djt435. [Abstract]
  • Wilmott, J., Haydu, L., Menzies, A., Lum, T., Hyman, J., Thompson, J., Hersey, P., Kefford, R., Scolyer, R., Long, G. (2014), Dynamics of Chemokine, Cytokine, and Growth Factor Serum Levels in BRAF-Mutant Melanoma Patients during BRAF Inhibitor Treatment. Journal of Immunology. 192(5), 2505-2513. [Abstract]
  • Kaufman, K., Mactier, S., Armstrong, N., Mallawaaratchy, D., Byrne, S., Haydu, L., Jakrot, V., Thompson, J., Mann, G., Scolyer, R., Christopherson, R. (2014), Surface antigen profiles of leukocytes and melanoma cells in lymph node metastases are associated with survival in AJCC stage III melanoma patients. Clinical & Experimental Metastasis. 31, 407-421. [Abstract]
  • Larson, A., Dresser, K., Zhan, Q., Lezcano, C., Woda, B., Yosufi, B., Thompson, J., Scolyer, R., Mihm, M., Shi, Y., Murphy, G., Lian, C. (2014), Loss of 5-hydroxymethylcytosine correlates with increasing morphologic dysplasia in melanocytic tumors. Modern Pathology. 27(7), 936-944. [Abstract]
  • Schatton, T., Scolyer, R., Thompson, J., Mihm Jr, M. (2014), Tumor-Infiltrating Lymphocytes and Their Significance in Melanoma Prognosis. In: Methods in Molecular Biology: Vol 1102, Molecular Diagnostics for Melanoma. (pp.287-324).United States: Springer Science+Business.
  • van der Ploeg, A., van Akkooi, A., Haydu, L., Scolyer, R., Murali, R., Verhoef, C., Thompson, J., Eggermont, A. (2014), The prognostic significance of sentinel node tumour burden in melanoma patients: an international, multicenter study of 1539 sentinel node-positive melanoma patients. European Journal of Cancer. 50(1), 111-120. [Abstract]
  • Fogarty, G., Hong, A., Jacobsen, K., Reisse, C., Shivalingam, B., Burmeister, B., Haydu, L., Paton, E., Thompson, J. (2014), Accrual to a randomised trial of adjuvant whole brain radiotherapy for treatment of melanoma brain metastases is feasible. BMC Research Notes. 7(1), 412. [Abstract]
  • Song, E., Scolyer, R., Damian, D., Thompson, J. (2014), Primary oesophageal melanoma - a case report. World Journal of Surgical Oncology. 12, 77. [Abstract]

2013

   
  • Scolyer, R., Thompson, J. (2013), Biospecimen banking: The pathway to personalized medicine for patients with cancer. Journal of Surgical Oncology. 107, 681-682. [Abstract]
  • Peach, H., van der Ploeg, A., Haydu, L., Stretch, J., Shannon, K., Uren, R., Thompson, J. (2013), The Unpredictability of Lymphatic Drainage from the Ear in Melanoma Patients, and Its Implications for Management. Annals of Surgical Oncology. 20(5), 1707-1713. [Abstract]
  • Wevers, K., Murali, R., Bastiaannet, E., Scolyer, R., Suurmeijer, A., Thompson, J., Hoekstra, H. (2013), Assessment of a new scoring system for predicting non-sentinel node positivity in sentinel node-positive melanoma patients. European Journal of Surgical Oncology. 39(2), 179-184. [Abstract]
  • Dutton-Regester, K., Kakavand, H., Aoude, L., Stark, M., Gartside, M., Johansson, P., O'Connor, L., Lanagan, C., Tembe, V., Pupo, G., Haydu, L., Schmidt, C., Mann, G., Thompson, J., Scolyer, R., Hayward, N. (2013), Melanomas of unknown primary have a mutation profile consistent with cutaneous sun-exposed melanoma. Pigment Cell & Melanoma Research. 26(6), 852-860. [Abstract]
  • Balch, C., Soong, S., Gershenwald, J., Thompson, J., Coit, D., Atkins, M., Ding, S., Cochran, A., Eggermont, A., Flaherty, K., Gimotty, P., Johnson, T., Kirkwood, J., Leong, S., McMasters, K., Mihm, M., Morton, D., Ross, M., Sondak, V. (2013), Age as a prognostic factor in patients with localized melanoma and regional metastases. Annals of Surgical Oncology. 20(12), 3961-3968. [Abstract]
  • Rychetnik, L., McCaffery, K., Morton, R., Thompson, J., Menzies, S., Irwig, L. (2013), Follow-up of early stage melanoma: Specialist clinician perspectives on the functions of follow-up and implications for extending follow-up intervals. Journal of Surgical Oncology. 107(5), 463-468. [Abstract]
  • Murali, R., Scolyer, R., Thompson, J. (2013), Completion lymph node dissection in melanoma patients with positive sentinel lymph nodes. European Journal of Surgical Oncology. , 1164-1165. [Abstract]
  • Long, G., Wilmott, J., Capper, D., Preusser, M., Zhang, Y., Thompson, J., Kefford, R., von Deimling, A., Scolyer, R. (2013), Immunohistochemistry Is Highly Sensitive and Specific for the Detection of V600E BRAF Mutation in Melanoma. American Journal of Surgical Pathology. 37(1), 61-65. [Abstract]
  • Scolyer, R., Judge, M., Evans, A., Frishberg, D., Prieto, V., Thompson, J., Trotter, M., Walsh, M., Walsh, N., Ellis, D. (2013), Data set for pathology reporting of cutaneous invasive Melanoma: recommendations from the International Collaboration on Cancer Reporting (ICCR). The American Journal of Surgical Pathology. 37(12), 1797-1814. [Abstract]
  • Murali, R., Wilmott, J., Jakrot, V., Al-Ahmadie, H., Wiesner, T., McCarthy, S., Thompson, J., Scolyer, R. (2013), BAP1 expression in cutaneous melanoma: a pilot study. Pathology. 45(6), 606-609. [Abstract]
  • Kakavand, H., Scolyer, R., Thompson, J., Mann, G. (2013), Identification of new prognostic biomarkers for Stage III metastatic melanoma patients. Oncoimmunology. 2(9), e25564. [Abstract]
  • Mann, G., Pupo, G., Campain, A., Carter, C., Schramm, S., Pianova, S., Gerega, S., De Silva, C., Lai, K., Wilmott, J., Synnott, M., Hersey, P., Kefford, R., Thompson, J., Yang, Y., Scolyer, R. (2013), BRAF Mutation, NRAS Mutation, and the Absence of an Immune-Related Expressed Gene Profile Predict Poor Outcome in Patients with Stage III Melanoma. The Journal of Investigative Dermatology. 133(2), 509-517. [Abstract]
  • Mar, V., Wong, S., Li, J., Scolyer, R., McLean, C., Papenfuss, A., Tothill, R., Kakavand, H., Mann, G., Thompson, J., Behren, A., Cebon, J., Wolfe, R., Kelly, J., Dobrovic, A., McArthur, G. (2013), BRAF/NRAS Wild-Type Melanomas Have a High Mutation Load Correlating with Histologic and Molecular Signatures of UV Damage. Clinical Cancer Research. 19(17), 4589-4598. [Abstract]
  • Hruby, G., Scolyer, R., Thompson, J. (2013), The important role of radiation treatment in the management of Merkel cell carcinoma. The British Journal of Dermatology. 169(5), 975-982. [Abstract]
  • Niebling, M., Haydu, L., Karim, R., Thompson, J., Scolyer, R. (2013), Reproducibility of AJCC Staging Parameters in Primary Cutaneous Melanoma: An Analysis of 4,924 Cases. Annals of Surgical Oncology. 20(12), 3969-3975. [Abstract]
  • Ryu, S., Saw, R., Scolyer, R., Crawford, M., Thompson, J., Sandroussi, C. (2013), Liver resection for metastatic melanoma: Equivalent survival for cutaneous and ocular primaries. Journal of Surgical Oncology. 108(2), 129-135. [Abstract]
  • Harish, V., Bond, J., Scolyer, R., Haydu, L., Saw, R., Quinn, M., Benger, R., Uren, R., Stretch, J., Shannon, K., Thompson, J. (2013), Margins of excision and prognostic factors for cutaneous eyelid melanomas. Journal of Plastic, Reconstructive & Aesthetic Surgery. 66, 1066-1073. [Abstract]
  • Scolyer, R., Thompson, J. (2013), Mitotic rate in melanoma should be recorded as the number of mitoses per mm(2) (not per high power field): surgeons tell your pathologists!. American Journal of Surgery. , 142-143. [Abstract]
  • Long, G., Wilmott, J., Haydu, L., Tembe, V., Sharma, R., Rizos, H., Thompson, J., Howle, J., Scolyer, R., Kefford, R. (2013), Effects of BRAF inhibitors on human melanoma tissue before treatment, early during treatment and on progression. Pigment Cell and Melanoma Research. 26(4), 499-508. [Abstract]
  • Wilmott, J., Menzies, A., Haydu, L., Capper, D., Preusser, M., Zhang, Y., Thompson, J., Kefford, R., von Deimling, A., Scolyer, R., Long, G. (2013), BRAF(V600E) protein expression and outcome from BRAF inhibitor treatment in BRAF(V600E) metastatic melanoma. British Journal of Cancer. 108(4), 924-931. [Abstract]
  • Pasquali, S., Haydu, L., Scolyer, R., Winstanley, J., Spillane, A., Quinn, M., Saw, R., Shannon, K., Stretch, J., Thompson, J. (2013), The Importance of Adequate Primary Tumor Excision Margins and Sentinel Node Biopsy in Achieving Optimal Locoregional Control for Patients With Thick Primary Melanomas. Annals of Surgery. 258(1), 152-157. [Abstract]
  • Winstanley, J., Saw, R., Boyle, F., Thompson, J. (2013), The FACT-Melanoma Quality-of-Life Instrument: comparison of a five-point and four-point response scale using the Rasch measurement model. Melanoma Research. 23(1), 61-69. [Abstract]
  • Winstanley, J., White, E., Boyle, F., Thompson, J. (2013), What are the pertinent quality-of-life issues for melanoma cancer patients? Aiming for the development of a new module to accompany the EORTC core questionnaire. Melanoma Research. 23(2), 167-174. [Abstract]
  • Pasquali, S., van der Ploeg, A., Mocellin, S., Stretch, J., Thompson, J., Scolyer, R. (2013), Lymphatic biomarkers in primary melanomas as predictors of regional lymph node metastasis and patient outcomes. Pigment Cell & Melanoma Research. 26(3), 326-337. [Abstract]
  • Thompson, J., Menzies, A. (2013), Melanoma. Cancer Forum. 37(1), 65-66.
  • Morton, R., Rychetnik, L., McCaffery, K., Thompson, J., Irwig, L. (2013), Patients' perspectives of long-term follow-up for localised cutaneous melanoma. European Journal of Surgical Oncology. 39(39), 297-303. [Abstract]
  • Sondak, V., Wong, S., Gershenwald, J., Thompson, J. (2013), Evidence-based clinical practice guidelines on the use of sentinel lymph node biopsy in melanoma. Educational Book. 2013, 320-325. [Abstract]
  • Scolyer, R., Karim, R., Thompson, J., Stretch, J., McCarthy, S., Murali, R. (2013), Digital papillary adenocarcinoma: a tumour that should be considered in the differential diagnosis of neoplasms involving the digits. Pathology. 45(1), 55-61. [Abstract]
  • Shiau, C., Thompson, J., Scolyer, R. (2013), Controversies and evolving concepts in the diagnosis, classification and management of lentigo maligna. Expert Review of Dermatology. 8:2, 195-214.

2012

   
  • Kim, J., McCarthy, S., Thompson, J., Pupo, G., Vonthethoff, L., Nash, P., Mann, G., Scolyer, R. (2012), Cellular blue naevus involving the urinary bladder. Pathology. 44(7), 664-668. [Abstract]
  • Murali, R., Scolyer, R., Thompson, J. (2012), Can we better identify thin cutaneous melanomas that are likely to metastasize and cause death?. Annals of Surgical Oncology. 19(11), 3310-3312. [Abstract]
  • Gershenwald, J., Coit, D., Sondak, V., Thompson, J. (2012), The challenge of defining guidelines for sentinel lymph node biopsy in patients with thin primary cutaneous melanomas. Annals of Surgical Oncology. 19(11), 3301-3303. [Abstract]
  • Lian, C., Xu, Y., Ceol, C., Wu, F., Larson, A., Dresser, K., Xu, W., Tan, L., Hu, Y., Zhan, Q., Lee, C., Hu, D., Lian, B., Kleffel, S., Yang, Y., Neiswender, J., Khorasani, A., Fang, R., Lezcano, C., Duncan, L., Scolyer, R., Thompson, J., Kakavand, H., Houvras, Y., Zon, L., Mihm, M., Kaiser, U., Schatton, T., Woda, B., Murphy, G., Shi, Y. (2012), Loss of 5-hydroxymethylcytosine is an epigenetic hallmark of melanoma. Cell. 150(6), 1135-1146. [Abstract]
  • Wilmott, J., Tembe, V., Howle, J., Sharma, R., Thompson, J., Rizos, H., Lo, R., Kefford, R., Scolyer, R., Long, G. (2012), Intratumoral molecular heterogeneity in a BRAF-mutant, BRAF inhibitor-resistant melanoma: a case illustrating the challenges for personalized medicine. Molecular Cancer Therapeutics. 11(12), 2704-2708. [Abstract]
  • Howard, J., Thompson, J., Mozzillo, N., Nieweg, O., Hoekstra, H., Roses, D., Sondak, V., Reintgen, D., Kashani-Sabet, M., Karakousis, C., Coventry, B., Kraybill, W., Smithers, B., Elashoff, R., Stern, S., Cochran, A., Faries, M., Morton, D. (2012), Metastasectomy for Distant Metastatic Melanoma: Analysis of Data from the First Multicenter Selective Lymphadenectomy Trial (MSLT-I). Annals of Surgical Oncology. 19(8), 2547-2555. [Abstract]
  • Lim, C., Whalley, D., Haydu, L., Murali, R., Tippett, J., Thompson, J., Hruby, G., Scolyer, R. (2012), Increasing Tumor Thickness is Associated with Recurrence and Poorer Survival in Patients with Merkel Cell Carcinoma. Annals of Surgical Oncology. 19(11), 3325-3334. [Abstract]
  • Azimi, F., Scolyer, R., Rumcheva, P., Moncrieff, M., Murali, R., McCarthy, S., Saw, R., Thompson, J. (2012), Tumor-Infiltrating Lymphocyte Grade Is an Independent Predictor of Sentinel Lymph Node Status and Survival in Patients With Cutaneous Melanoma. Journal of Clinical Oncology. 30(21), 2678-2683. [Abstract]
  • Pasquali, S., Spillane, A., de Wilt, J., McCaffery, K., Rossi, C., Quinn, M., Saw, R., Shannon, K., Stretch, J., Thompson, J. (2012), Surgeons' Opinions on Lymphadenectomy in Melanoma Patients with Positive Sentinel Nodes: A Worldwide Web-Based Survey. Annals of Surgical Oncology. 19(13), 4322-4329. [Abstract]
  • Spillane, A., Thompson, J. (2012), Sentinel node biopsy for breast cancer: then and now. ANZ Journal of Surgery. 82, 481-483. [Abstract]
  • Thompson, J., Scolyer, R., Kefford, R. (2012), Melanoma - a management guide for GPs. Australian Family Physician. 41(7), 470-473. [Abstract]
  • Murali, R., Brown, P., Kefford, R., Scolyer, R., Thompson, J., Atkins, M., Long, G. (2012), Number of primary melanomas is an independent predictor of survival in patients with metastatic melanoma. Cancer. 118(18), 4519-4529. [Abstract]
  • Menzies, A., Haydu, L., Visintin, L., Carlino, M., Howle, J., Thompson, J., Kefford, R., Scolyer, R., Long, G. (2012), Distinguishing Clinicopathologic Features of Patients with V600E and V600K BRAF-Mutant Metastatic Melanoma. Clinical Cancer Research. 18(12), 3242-3249. [Abstract]
  • Martin, R., Shannon, K., Quinn, M., Saw, R., Spillane, A., Stretch, J., Colman, M., Gao, K., Thompson, J. (2012), The Management of Cervical Lymph Nodes in Patients with Cutaneous Melanoma. Annals of Surgical Oncology. 19(12), 3926-3932. [Abstract]
  • Takei, Y., Huynh, K., Kuo, C., Scolyer, R., Murali, R., Chong, K., Takeshima, L., Sim, M., Morton, D., Turner, R., Thompson, J., Hoon, D. (2012), Aberrant Hypermethylation in Primary and Sentinel Lymph Node Metastases in Pediatric Cutaneous Melanoma Patients. The British Journal of Dermatology. 166(6), 1319-1326. [Abstract]
  • Thompson, J., Hong, A., Fogarty, G. (2012), Publication and Interpretation of Clinical Trial Results: The Need for Caution. Annals of Surgical Oncology. 19, 1745-1747. [Abstract]
  • Chua, T., Scolyer, R., Kennedy, C., Yan, T., McCaughan, B., Thompson, J. (2012), Surgical Management of Melanoma Lung Metastasis: An Analysis of Survival Outcomes in 292 Consecutive Patients. Annals of Surgical Oncology. 19(6), 1774-1781. [Abstract]
  • In ʼt Hout, F., Haydu, L., Murali, R., Bonenkamp, J., Thompson, J., Scolyer, R. (2012), Prognostic Importance of the Extent of Ulceration in Patients With Clinically Localized Cutaneous Melanoma. Annals of Surgery. 255(6), 1165-1170. [Abstract]
  • Murali, R., Haydu, L., Long, G., Quinn, M., Saw, R., Shannon, K., Spillane, A., Stretch, J., Kefford, R., Thompson, J., Scolyer, R. (2012), Clinical and Pathologic Factors Associated with Distant Metastasis and Survival in Patients with Thin Primary Cutaneous Melanoma. Annals of Surgical Oncology. 19(6), 1782-1789. [Abstract]
  • Burmeister, B., Henderson, M., Ainslie, J., Fisher, R., Di Iulio, J., Smithers, B., Hong, A., Shannon, K., Scolyer, R., Carruthers, S., Coventry, B., Babington, S., Duprat, J., Hoekstra, H., Thompson, J. (2012), Adjuvant radiotherapy versus observation alone for patients at risk of lymph-node field relapse after therapeutic lymphadenectomy for melanoma: a randomised trial. The Lancet Oncology. 13(6), 589-597. [Abstract]
  • Spillane, A., Haydu, L., Lee, N., Uren, R., Stretch, J., Shannon, K., Quinn, M., Saw, R., McCarthy, W., Thompson, J. (2012), Evaluation of Incomplete Sentinel Node Biopsy Procedures and Sentinel Node Positivity Rates as Surgical Quality-Assurance Parameters in Melanoma Patients. Annals of Surgical Oncology. 19(12), 3919-3925. [Abstract]
  • Sundaresan, P., Hruby, G., Hamilton, A., Hong, A., Boyer, M., Chatfield, M., Thompson, J. (2012), Definitive Radiotherapy or Chemoradiotherapy in the Treatment of Merkel Cell Carcinoma. Clinical Oncology. 24(9), e131-e136. [Abstract]
  • Shayan, R., Karnezis, T., Murali, R., Wilmott, J., Ashton, M., Taylor, G., Thompson, J., Hersey, P., Achen, M., Scolyer, R., Stacker, S. (2012), Lymphatic vessel density in primary melanomas predicts sentinel lymph node status and risk of metastasis. Histopathology. 61(4), 702-710. [Abstract]
  • Huismans, A., Kroon, H., Haydu, L., Kam, P., Thompson, J. (2012), Is Melphalan Dose Adjustment According to Ideal Body Weight Useful in Isolated Limb Infusion for Melanoma?. Annals of Surgical Oncology. 19(9), 3050-3056. [Abstract]
  • Tran, S., Haferkamp, S., Scurr, L., Gowrishankar, K., Becker, T., Desilva, C., Thompson, J., Scolyer, R., Kefford, R., Rizos, H. (2012), Absence of Distinguishing Senescence Traits in Human Melanocytic Nevi. Journal of Investigative Dermatology. 132(9), 2226-2234. [Abstract]
  • Murali, R., DeSilva, C., McCarthy, S., Thompson, J., Scolyer, R. (2012), Sentinel lymph nodes containing very small (<0.1 mm) deposits of metastatic melanoma cannot be safely regarded as tumor-negative. Annals of Surgical Oncology. 19(4), 1089-1099. [Abstract]
  • Bastiaannet, E., Uyl-de Groot, C., Brouwers, A., van der Jagt, E., Hoekstra, O., Oyen, W., Verzijlbergen, F., van Ooijen, B., Thompson, J., Hoekstra, H. (2012), Cost-effectiveness of adding FDG-PET or CT to the diagnostic work-up of patients with stage III melanoma. Annals of Surgery. 255(4), 771-776. [Abstract]
  • Lim, C., Thompson, J., McKenzie, P., McCarthy, S., Scolyer, R. (2012), Peritoneal melanosis associated with metastatic melanoma involving the omentum. Pathology. , 255-257. [Abstract]
  • Wilmott, J., Haydu, L., Bagot, M., Zhang, Y., Jakrot, V., McCarthy, S., Lugassy, C., Thompson, J., Scolyer, R., Barnhill, R. (2012), Angiotropism is an independent predictor of microscopic satellites in primary cutaneous melanoma. Histopathology. 61(5), 889-898. [Abstract]
  • Wilmott, J., Long, G., Howle, J., Haydu, L., Sharma, R., Thompson, J., Kefford, R., Hersey, P., Scolyer, R. (2012), Selective BRAF inhibitors induce marked T cell infiltration into human metastatic melanoma. Clinical Cancer Research. 18(5), 1386-1394. [Abstract]
  • Girouard, S., Laga, A., Mihm, M., Scolyer, R., Thompson, J., Zhan, Q., Widlund, H., Lee, C., Murphy, G. (2012), SOX2 contributes to melanoma cell invasion. Laboratory Investigation. 92(3), 362-370. [Abstract]
  • Hoshimoto, S., Faries, M., Morton, D., Shingai, T., Kuo, C., Wang, H., Elashoff, R., Mozzillo, N., Kelley, M., Thompson, J., Lee, J., Hoon, D. (2012), Assessment of Prognostic Circulating Tumor Cells in a Phase III Trial of Adjuvant Immunotherapy After Complete Resection of Stage IV Melanoma. Annals of surgery. 255(2), 357-62. [Abstract]
  • Burmeister, B., Henderson, M., Thompson, J. (2012), Adjuvant nodal irradiation in melanoma- Authors' reply. The Lancet Oncology. , e327.
  • Murali, R., Haydu, L., Quinn, M., Saw, R., Shannon, K., Spillane, A., Stretch, J., Thompson, J., Scolyer, R. (2012), Sentinel Lymph Node Biopsy in Patients With Thin Primary Cutaneous Melanoma. Annals of Surgery. 255(1), 128-133. [Abstract]
  • Rychetnik, L., Morton, R., McCaffery, K., Thompson, J., Menzies, S., Irwig, L. (2012), Shared care in the follow-up of early-stage melanoma: a qualitative study of Australian melanoma clinicians' perspectives and models of care. BMC Health Services Research. 12, 468. [Abstract]

2011

   
  • Turner, R., Bell, K., Morton, R., Hayen, A., Francken, A., Howard, K., Armstrong, B., Thompson, J., Irwig, L. (2011), Optimizing the Frequency of Follow-Up Visits for Patients Treated for Localized Primary Cutaneous Melanoma. Journal of Clinical Oncology. 29(35), 4641-4646. [Abstract]
  • Damian, D., Thompson, J. (2011), Topical diphencyprone immunotherapy for a large primary melanoma on an elderly leg. American Journal of Clinical Dermatology. 12(6), 403-404. [Abstract]
  • Thompson, J., Ollila, D. (2011), Optimum excision margins for melanoma. Lancet. 378(9803), 1608-10. [Abstract]
  • Nielsen, K., Chakera, A., Hesse, B., Scolyer, R., Stretch, J., Thompson, J., Nielsen, M., Uren, R., Oturai, P. (2011), The diagnostic value of adding dynamic scintigraphy to standard delayed planar imaging for sentinel node identification in melanoma patients. European Journal of Nuclear Medicine and Molecular Imaging. 38(11), 1999-2004. [Abstract]
  • Verwer, N., Scolyer, R., Uren, R., Winstanley, J., Brown, P., de Wilt, J., Thompson, J. (2011), Treatment and Prognostic Significance of Positive Interval Sentinel Nodes in Patients with Primary Cutaneous Melanoma. Annals of surgical oncology. 18(12), 3292-9. [Abstract]
  • Sunderland, N., Thomson, S., Heffernan, S., Lim, S., Thompson, J., Ogle, R., McKenzie, P., Kirwan, P., Makris, A., Hennessy, A. (2011), Tumor necrosis factor α induces a model of preeclampsia in pregnant baboons (Papio hamadryas). Cytokine. 56(2), 192-9. [Abstract]
  • Spillane, A., Haydu, L., McMillan, W., Stretch, J., Thompson, J. (2011), Quality Assurance Parameters and Predictors of Outcome for Ilioinguinal and Inguinal Dissection in a Contemporary Melanoma Patient Population. Annals of Surgical Oncology. 18(9), 2521-2528. [Abstract]
  • Thompson, J., Haydu, L., Sanki, A., Uren, R. (2011), Ultrasound assessment of lymph nodes in the management of early-stage melanoma. Journal of Surgical Oncology. 104(4), 354-360. [Abstract]
  • Uren, R., Howman-Giles, R., Chung, D., Thompson, J. (2011), Guidelines for lymphoscintigraphy and F18 FDG PET scans in Melanoma. Journal of Surgical Oncology. 104(4), 405-419. [Abstract]
  • Balch, C., Gershenwald, J., Soong, S., Thompson, J. (2011), Update on the melanoma staging system: the importance of sentinel node staging and primary tumor mitotic rate. Journal of Surgical Oncology. 104(4), 379-385. [Abstract]
  • Testori, A., Verhoef, C., Kroon, H., Pennacchioli, E., Faries, M., Eggermont, A., Thompson, J. (2011), Treatment of melanoma metastases in a limb by isolated limb perfusion and isolated limb infusion. Journal of Surgical Oncology. 104(4), 397-404. [Abstract]
  • Testori, A., Faries, M., Thompson, J., Pennacchioli, E., Deroose, J., van Geel, A., Verhoef, C., Verrecchia, F., Soteldo, J. (2011), Local and intralesional therapy of in-transit melanoma metastases. Journal of Surgical Oncology. 104(4), 391-396. [Abstract]
  • Schrama, D., Peitsch, W., Zapatka, M., Kneitz, H., Houben, R., Eib, S., Haferkamp, S., Moore, P., Shuda, M., Thompson, J., Trefzer, U., Pföhler, C., Scolyer, R., Becker, J. (2011), Merkel cell polyomavirus status is not associated with clinical course of Merkel cell carcinoma. Journal of Investigative Dermatology. 131(8), 1631-1638. [Abstract]
  • Huismans, A., Kroon, H., Kam, P., Thompson, J. (2011), Does Increased Experience with Isolated Limb Infusion for Advanced Limb Melanoma Influence Outcome? A Comparison of Two Treatment Periods at a Single Institution. Annals of surgical oncology. 18(7), 1877-83. [Abstract]
  • Murali, R., Desilva, C., Thompson, J., Scolyer, R. (2011), Factors Predicting Recurrence and Survival in Sentinel Lymph Node-Positive Melanoma Patients. Annals of surgery. 253(6), 1155-64. [Abstract]
  • Thompson, J., Soong, S., Balch, C., Gershenwald, J., Ding, S., Coit, D., Flaherty, K., Gimotty, P., Johnson, T., Johnson, M., Leong, S., Ross, M., Byrd, D., Cascinelli, N., Cochran, A., Eggermont, A., McMasters, K., Mihm, M., Morton, D., Sondak, V. (2011), Prognostic Significance of Mitotic Rate in Localized Primary Cutaneous Melanoma: An Analysis of Patients in the Multi-Institutional American Joint Committee on Cancer Melanoma Staging Database. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 29(16), 2199-205. [Abstract]
  • Sanki, A., Kroon, H., Kam, P., Thompson, J. (2011), Isolated limb perfusion and isolated limb infusion for malignant lesions of the extremities. Current Problems in Surgery. 48(6), 371-430. [Abstract]
  • Sanki, A., Kroon, H., Kam, P., Thompson, J. (2011), In brief. Current Problems in Surgery. 48(6), 366-369. [Abstract]
  • Murali, R., Zannino, D., Synnott, M., McCarthy, S., Thompson, J., Scolyer, R. (2011), Clinical and pathological features of metastases of primary cutaneous desmoplastic melanoma. Histopathology. 58(6), 886-95. [Abstract]
  • Prakoso, E., Fulham, M., Thompson, J., Selby, W. (2011), Capsule endoscopy versus positron emission tomography for detection of small-bowel metastatic melanoma: a pilot study. Gastrointestinal Endoscopy. 73(4), 750-756. [Abstract]
  • Scolyer, R., Long, G., Thompson, J. (2011), Evolving concepts in melanoma classification and their relevance to multidisciplinary melanoma patient care. Molecular oncology. 5(2), 124-36. [Abstract]
  • Long, G., Menzies, A., Nagrial, A., Haydu, L., Hamilton, A., Mann, G., Hughes, T., Thompson, J., Scolyer, R., Kefford, R. (2011), Prognostic and Clinicopathologic Associations of Oncogenic BRAF in Metastatic Melanoma. Journal of Clinical Oncology. 29(10), 1239-1246. [Abstract]
  • Chmiel, K., Suan, D., Liddle, C., Nankivell, B., Ibrahim, R., Bautista, C., Thompson, J., Fulcher, D., Kefford, R. (2011), Resolution of Severe Ipilimumab-Induced Hepatitis After Antithymocyte Globulin Therapy. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 29(9), e237-40. [Abstract]
  • Svobodová, S., Browning, J., MacGregor, D., Pollara, G., Scolyer, R., Murali, R., Thompson, J., Deb, S., Azad, A., Davis, I., Cebon, J. (2011), Cancer-testis antigen expression in primary cutaneous melanoma has independent prognostic value comparable to that of Breslow thickness, ulceration and mitotic rate. European Journal of Cancer. 47(3), 460-469. [Abstract]
  • Fogarty, G., Morton, R., Vardy, J., Nowak, A., Mandel, C., Forder, P., Hong, A., Hruby, G., Burmeister, B., Shivalingam, B., Dhillon, H., Thompson, J. (2011), Whole brain radiotherapy after local treatment of brain metastases in melanoma patients - a randomised phase III trial. BMC cancer. 11(1), 142. [Abstract]
  • Ross, M., Thompson, J., Gershenwald, J. (2011), Sentinel lymph node biopsy for melanoma: critical assessment at its twentieth anniversary. Surgical Oncology Clinics of North America. 20(1), 57-78. [Abstract]
  • Spillane, A., Cheung, B., Winstanley, J., Thompson, J. (2011), Lymph Node Ratio Provides Prognostic Information in Addition to American Joint Committee on Cancer N Stage in Patients With Melanoma, Even If Quality of Surgery Is Standardized. Annals of Surgery. 253(1), 109-115. [Abstract]

2010

   
  • Scolyer, R., Murali, R., McCarthy, S., Thompson, J. (2010), Histologically ambiguous ("borderline") primary cutaneous melanocytic tumors: approaches to patient management including the roles of molecular testing and sentinel lymph node biopsy. Archives of Pathology & Laboratory Medicine. 134(12), 1770-1777. [Abstract]
  • Martiniuk, F., Damian, D., Thompson, J., Scolyer, R., Tchou-Wong, K., Levis, W. (2010), TH17 is involved in the remarkable regression of metastatic malignant melanoma to topical diphencyprone. Journal of Drugs in Dermatology. 9(11), 1368-1372. [Abstract]
  • Cadili, A., Scolyer, R., Brown, P., Dabbs, K., Thompson, J. (2010), Total sentinel lymph node tumor size predicts nonsentinel node metastasis and survival in patients with melanoma. Annals of Surgical Oncology. 17(11), 3015-3020. [Abstract]
  • Murali, R., Moncrieff, M., Hong, J., Cooper, C., Shingde, M., Samuel, D., Thompson, J., Scolyer, R. (2010), The Prognostic Value of Tumor Mitotic Rate and Other Clinicopathologic Factors in Patients with Locoregional Recurrences of Melanoma. Annals of surgical oncology. 17(11), 2992-9. [Abstract]
  • Murali, R., Desilva, C., Thompson, J., Scolyer, R. (2010), Non-Sentinel Node Risk Score (N-SNORE): A Scoring System for Accurately Stratifying Risk of Non-Sentinel Node Positivity in Patients With Cutaneous Melanoma With Positive Sentinel Lymph Nodes. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 28(29), 4441-9. [Abstract]
  • Cadili, A., Dabbs, K., Scolyer, R., Brown, P., Thompson, J. (2010), Re-evaluation of a scoring system to predict nonsentinel-node metastasis and prognosis in melanoma patients. Journal of the American College of Surgeons. 211(4), 522-525. [Abstract]
  • Kam, P., Thompson, J. (2010), Isolated limb infusion with melphalan and actinomycin D in melanoma patients: factors predictive of acute regional toxicity. Expert opinion on drug metabolism & toxicology. 6(9), 1039-45. [Abstract]
  • Verwer, N., Murali, R., Winstanley, J., Cooper, W., Stretch, J., Thompson, J., Scolyer, R. (2010), Lymphoma occurring in patients with cutaneous melanoma. Journal of Clinical Pathology. 63(9), 777-781. [Abstract]
  • Murali, R., Shaw, H., Lai, K., McCarthy, S., Quinn, M., Stretch, J., Thompson, J., Scolyer, R. (2010), Prognostic factors in cutaneous desmoplastic melanoma: a study of 252 patients. Cancer. 116(17), 4130-8. [Abstract]
  • Wiener, M., Acland, K., Shaw, H., Soong, S., Lin, H., Chen, D., Scolyer, R., Winstanley, J., Thompson, J. (2010), Sentinel Node Positive Melanoma Patients: Prediction and Prognostic Significance of Nonsentinel Node Metastases and Development of a Survival Tree Model. Annals of surgical oncology. 17(8), 1995-2005. [Abstract]
  • Guitera, P., Bourgeat, P., Stretch, J., Scolyer, R., Ourselin, S., Lean, C., Thompson, J., Bourne, R. (2010), Diagnostic value of 8.5 T magnetic resonance spectroscopy of benign and malignant skin lesion biopsies. Melanoma Research. 20(4), 311-317. [Abstract]
  • Moncrieff, M., Thompson, J., Stretch, J. (2010), Extended experience and modifications in the design and concepts of the keystone design island flap. Journal of plastic, reconstructive & aesthetic surgery : JPRAS. 63(0), 1359-63. [Abstract]
  • Soong, S., Ding, S., Coit, D., Balch, C., Gershenwald, J., Thompson, J., Gimotty, P. (2010), Predicting survival outcome of localized melanoma: an electronic prediction tool based on the AJCC Melanoma Database. Annals of Surgical Oncology. 17(8), 2006-2014. [Abstract]
  • Cooper, C., Murali, R., Doubrovsky, A., Watson, G., McKenzie, P., Thompson, J., Scolyer, R. (2010), Synchronous and metachronous malignancies in patients with melanoma: a clinicopathologic study highlighting the role of fine-needle biopsy cytology and potential diagnostic pitfalls. Melanoma research. 20(3), 203-11. [Abstract]
  • Murali, R., Thompson, J., Scolyer, R. (2010), Can Histologic Parameters of Melanoma Metastases in Sentinel Lymph Nodes Reliably Select Patients Who Can Be Safely Spared Completion Lymph Node Dissection?. Annals of surgery. , 1188-9; author reply 1189-90. [Abstract]
  • Balch, C., Gershenwald, J., Soong, S., Thompson, J., Ding, S., Byrd, D., Cascinelli, N., Cochran, A., Coit, D., Eggermont, A., Johnson, T., Kirkwood, J., Leong, S., McMasters, K., Mihm, M., Morton, D., Ross, M., Sondak, V. (2010), Multivariate Analysis of Prognostic Factors Among 2,313 Patients With Stage III Melanoma: Comparison of Nodal Micrometastases Versus Macrometastases. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 28(14), 2452-9. [Abstract]
  • Haydu, L., Holt, P., Karim, R., Madronio, C., Thompson, J., Armstrong, B., Scolyer, R. (2010), Quality of histopathological reporting on melanoma and influence of use of a synoptic template. Histopathology. 56(6), 768-774. [Abstract]
  • Murali, R., Field, A., McKenzie, P., McLeod, D., Stretch, J., Thompson, J., Scolyer, R. (2010), Melanotic schwannoma mimicking metastatic pigmented melanoma: a pitfall in cytological diagnosis. Pathology. 42(3), 287-289. [Abstract]
  • Murali, R., Thompson, J., Uren, R., Scolyer, R. (2010), Fine-needle biopsy of metastatic melanoma: clinical use and new applications. The lancet oncology. 11(4), 391-400. [Abstract]
  • Reynolds, H., Walker, C., Dunbar, P., O'Sullivan, M., Uren, R., Thompson, J., Smith, N. (2010), Functional anatomy of the lymphatics draining the skin: a detailed statistical analysis. Journal of Anatomy. 216(3), 344-355. [Abstract]
  • Morton, R., Howard, K., Thompson, J. (2010), In Reply: Cost Effectiveness of Staging Procedures in Patients with Stage I/II Melanoma. Annals of Surgical Oncology. 17(2), 663-664. [Abstract]
  • Christou, E., Damian, D., Thompson, J. (2010), Regressing metastatic melanoma and vitiligo-like depigmentation in an Indigenous Australian. The Medical Journal of Australia. 192(3), 171. [Abstract]
  • Moncrieff, M., Spira, K., Clark, J., Thompson, J., Clifford, A., O'Brien, C., Shannon, K. (2010), Free flap reconstruction for melanoma of the head and neck: indications and outcomes. Journal of plastic, reconstructive & aesthetic surgery : JPRAS. 63(2), 205-12. [Abstract]
  • Balasuriya, H., Bell, P., Waugh, R., Thompson, J., Gillin, A., Hennessy, A., Makris, A. (2010), Primate maternal placental angiography. Placenta. 31(1), 32-6. [Abstract]
  • Howman-Giles, R., Shaw, H., Scolyer, R., Murali, R., Wilmott, J., McCarthy, S., Uren, R., Thompson, J. (2010), Sentinel Lymph Node Biopsy in Pediatric and Adolescent Cutaneous Melanoma Patients. Annals of surgical oncology. 17(0), 138-43. [Abstract]
  • Murali, R., Thompson, J., Scolyer, R. (2010), Location of Melanoma Metastases in Sentinel Lymph Nodes: What are the Implications for Histologic Processing of Sentinel Lymph Nodes in Routine Practice?. The American Journal of Surgical Pathology. 34(1), 127-129. [Abstract]
  • Faries, M., Thompson, J., Cochran, A., Elashoff, R., Glass, E., Mozzillo, N., Nieweg, O., Roses, D., Hoekstra, H., Karakousis, C., Reintgen, D., Coventry, B., Wang, H., Morton, D. (2010), The Impact on Morbidity and Length of Stay of Early Versus Delayed Complete Lymphadenectomy in Melanoma: Results of the Multicenter Selective Lymphadenectomy Trial (I). Annals of Surgical Oncology. 17, 3324-3329. [Abstract]
  • Zhuang, L., Scolyer, R., Murali, R., McCarthy, S., Zhang, X., Thompson, J., Hersey, P. (2010), Lactate dehydrogenase 5 expression in melanoma increases with disease progression and is associated with expression of Bcl-XL and Mcl-1, but not Bcl-2 proteins. Modern Pathology. 23(1), 45-53. [Abstract]

2009

   
  • Balch, C., Gershenwald, J., Soong, S., Thompson, J., Atkins, M., Byrd, D., Buzaid, A., Cochran, A., Coit, D., Ding, S., Eggermont, A., Flaherty, K., Gimotty, P., Kirkwood, J., McMasters, K., Mihm, M., Morton, D., Ross, M., Sober, A., Sondak, V. (2009), Final Version of 2009 AJCC Melanoma Staging and Classification. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 27(36), 6199-206. [Abstract]
  • Mocellin, S., Thompson, J., Pasquali, S., Montesco, M., Pilati, P., Nitti, D., Saw, R., Scolyer, R., Stretch, J., Rossi, C. (2009), Sentinel node status prediction by four statistical models: results from a large bi-institutional series (n = 1132). Annals of Surgery. 250(6), 964-969. [Abstract]
  • Sanki, A., Uren, R., Moncrieff, M., Tran, K., Scolyer, R., Lin, H., Thompson, J. (2009), Targeted High-Resolution Ultrasound Is Not an Effective Substitute for Sentinel Lymph Node Biopsy in Patients With Primary Cutaneous Melanoma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 27(33), 5614-9. [Abstract]
  • Damian, D., Shannon, K., Saw, R., Thompson, J. (2009), Topical diphencyprone immunotherapy for cutaneous metastatic melanoma. Australasian Journal of Dermatology. 50(4), 266-271. [Abstract]
  • Murali, R., Cochran, A., Cook, M., Hillman, J., Karim, R., Moncrieff, M., Starz, H., Thompson, J., Scolyer, R. (2009), Interobserver reproducibility of histologic parameters of melanoma deposits in sentinel lymph nodes: implications for management of patients with melanoma. Cancer. 115(21), 5026-37. [Abstract]
  • Guminski, A., Thompson, J. (2009), Predicting response to IL-2 therapy for metastatic melanoma. Expert Review of Anticancer Therapy. 9(11), 1571-1575. [Abstract]
  • Thompson, J., Morton, R. (2009), In Reply: Cost-Effectiveness of Sentinel Node Biopsy for Melanoma. Annals of Surgical Oncology. 16(10), 2962-2963. [Abstract]
  • Karim, R., Li, W., Sanki, A., Colman, M., Yang, Y., Thompson, J., Scolyer, R. (2009), Reduced p16 and increased cyclin D1 and pRb expression are correlated with progression in cutaneous melanocytic tumors. International Journal of Surgical Pathology. 17(5), 361-367. [Abstract]
  • Chakera, A., Hesse, B., Burak, Z., Ballinger, J., Britten, A., Caracò, C., Cochran, A., Cook, M., Drzewiecki, K., Essner, R., Even-Sapir, E., Eggermont, A., Stopar, T., Ingvar, C., Mihm, M., McCarthy, S., Mozzillo, N., Nieweg, O., Scolyer, R., Starz, H., Thompson, J., Trifirò, G., Viale, G., Vidal-Sicart, S., Uren, R., Waddington, W., Chiti, A., Spatz, A., Testori, A. (2009), EANM-EORTC general recommendations for sentinel node diagnostics in melanoma. European Journal of Nuclear Medicine and Molecular Imaging. 36(10), 1713-1742. [Abstract]
  • Shingde, M., Buckland, M., Busam, K., McCarthy, S., Wilmott, J., Thompson, J., Scolyer, R. (2009), Primary cutaneous Ewing sarcoma/primitive neuroectodermal tumour: a clinicopathological analysis of seven cases highlighting diagnostic pitfalls and the role of FISH testing in diagnosis. Journal of Clinical Pathology. 62(10), 915-919. [Abstract]
  • Reynolds, H., Smith, N., Uren, R., Thompson, J., Dunbar, P. (2009), Three-dimensional visualization of skin lymphatic drainage patterns of the head and neck. Head & neck. 31(10), 1316-25. [Abstract]
  • Busam, K., Murali, R., Pulitzer, M., McCarthy, S., Thompson, J., Shaw, H., Brady, M., Coit, D., Dusza, S., Wilmott, J., Kayton, M., Laquaglia, M., Scolyer, R. (2009), Atypical Spitzoid Melanocytic Tumors With Positive Sentinel Lymph Nodes in Children and Teenagers, and Comparison With Histologically Unambiguous and Lethal Melanomas. The American journal of surgical pathology. 33(9), 1386-95. [Abstract]
  • Narita, N., Tanemura, A., Murali, R., Scolyer, R., Huang, S., Arigami, T., Yanagita, S., Chong, K., Thompson, J., Morton, D., Hoon, D. (2009), Functional RET G691S polymorphism in cutaneous malignant melanoma. Oncogene. 28(34), 3058-68. [Abstract]
  • Thompson, J., Scolyer, R., Kefford, R. (2009), Cutaneous melanoma in the era of molecular profiling. Lancet. 374(9687), 362-365. [Abstract]
  • Orlow, I., Tommasi, D., Bloom, B., Ostrovnaya, I., Cotignola, J., Mujumdar, U., Busam, K., Jungbluth, A., Scolyer, R., Thompson, J., Armstrong, B., Berwick, M., Thomas, N., Begg, C. (2009), Evaluation of the Clonal Origin of Multiple Primary Melanomas Using Molecular Profiling. The Journal of investigative dermatology. 129(8), 1972-82. [Abstract]
  • Moncrieff, M., Thompson, J., Quinn, M., Stretch, J. (2009), Reconstruction after wide excision of primary cutaneous melanomas: part II--the extremities. The Lancet Oncology. 10(8), 810-815. [Abstract]
  • Kroon, H., Thompson, J. (2009), Isolated limb infusion: A review. Journal of surgical oncology. 100(2), 169-77. [Abstract]
  • Murali, R., Loughman, N., McKenzie, P., Watson, G., Thompson, J., Scolyer, R. (2009), Cytological features of melanoma in exfoliative fluid specimens. Journal of clinical pathology. 62(7), 638-643. [Abstract]
  • Moncrieff, M., Thompson, J., Quinn, M., Stretch, J. (2009), Reconstruction after wide excision of primary cutaneous melanomas: part I-the head and neck. The Lancet Oncology. 10(7), 700-708. [Abstract]
  • Martin, R., Murali, R., Scolyer, R., Fitzgerald, P., Colman, M., Thompson, J. (2009), So-called "malignant blue nevus": a clinicopathologic study of 23 patients. Cancer. 115(13), 2949-55. [Abstract]
  • Kroon, H., Lin, D., Kam, P., Thompson, J. (2009), Safety and efficacy of isolated limb infusion with cytotoxic drugs in elderly patients with advanced locoregional melanoma. Annals of surgery. 249(6), 1008-1013. [Abstract]
  • Kroon, H., Lin, D., Kam, P., Thompson, J. (2009), Major amputation for irresectable extremity melanoma after failure of isolated limb infusion. Annals of Surgical Oncology. 16(6), 1543-1547. [Abstract]
  • Spillane, A., Winstanley, J., Thompson, J. (2009), Lymph node ratio in melanoma: A marker of variation in surgical quality?. Cancer. 115, 2384-2387. [Abstract]
  • Kroon, H., Lin, D., Kam, P., Thompson, J. (2009), Isolated limb infusion as palliative treatment for advanced limb disease in patients with AJCC stage IV melanoma. Annals of Surgical Oncology. 16(5), 1193-1201. [Abstract]
  • Balch, C., Morton, D., Gershenwald, J., McMasters, K., Nieweg, O., Powell, B., Ross, M., Sondak, V., Thompson, J. (2009), Sentinel node biopsy and standard of care for melanoma. Journal of the American Academy of Dermatology. 60(5), 872-875. [Abstract]
  • Kroon, H., Moncrieff, M., Kam, P., Thompson, J. (2009), Factors predictive of acute regional toxicity after isolated limb infusion with melphalan and actinomycin D in melanoma patients. Annals of surgical oncology. 16(5), 1184-1192. [Abstract]
  • Kroon, H., Lin, D., Kam, P., Thompson, J. (2009), Efficacy of repeat isolated limb infusion with melphalan and actinomycin D for recurrent melanoma. Cancer. 115(9), 1932-1940. [Abstract]
  • Morton, R., Howard, K., Thompson, J. (2009), The Cost-Effectiveness of Sentinel Node Biopsy in Patients with Intermediate Thickness Primary Cutaneous Melanoma. Annals of Surgical Oncology. 16(4), 929-940. [Abstract]
  • Murali, R., Hughes, M., Fitzgerald, P., Thompson, J., Scolyer, R. (2009), Interobserver variation in the histopathologic reporting of key prognostic parameters, particularly clark level, affects pathologic staging of primary cutaneous melanoma. Annals of Surgery. 249(4), 641-647. [Abstract]
  • Lam, T., Uren, R., Scolyer, R., Quinn, M., Shannon, K., Thompson, J. (2009), False-negative sentinel node biopsy because of obstruction of lymphatics by metastatic melanoma: the value of ultrasound in conjunction with preoperative lymphoscintigraphy. Melanoma Research. 19(2), 94-99. [Abstract]
  • Kroon, H., Thompson, J., Hoekstra, H. (2009), Isolatie-infusie effectief bij melanoom en sarcoom [Isolated infusion effective in melanoma and sarcoma. Good alternative for regional isolated cytostatic perfusion]. Nederlands Tijdschrift voor Geneeskunde. 153(11), 508-514. [Abstract]
  • Morton, R., Craig, J., Thompson, J. (2009), The Role of Surveillance Chest X-Rays in the Follow-Up of High-Risk Melanoma Patients. Annals of surgical oncology. 16(3), 571-7. [Abstract]
  • Zhuang, L., Scolyer, R., Lee, C., McCarthy, S., Cooper, W., Zhang, X., Thompson, J., Hersey, P. (2009), Expression of glucose-regulated stress protein GRP78 is related to progression of melanoma. Histopathology. 54(4), 462-470. [Abstract]
  • Sanki, A., Scolyer, R., Thompson, J. (2009), Surgery for melanoma metastases of the gastrointestinal tract: Indications and results. European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology. 35(0), 313-9. [Abstract]
  • Hare, D., Burger, F., Austin, C., Fryer, F., Grimm, R., Reedy, B., Scolyer, R., Thompson, J., Doble, P. (2009), Elemental bio-imaging of melanoma in lymph node biopsies. The Analyst. 134(3), 450-453. [Abstract]
  • Spillane, A., Cheung, B., Stretch, J., Scolyer, R., Shannon, K., Quinn, M., Saw, R., McCarthy, W., Thompson, J. (2009), Proposed quality standards for regional lymph node dissections in patients with melanoma. Annals of Surgery. 249(3), 473-480. [Abstract]
  • Stephens, F., Aigner, K., Allen-Mersh, T., Hortobagyi, G., Khayat, D., Picksley, S., Sugarbaker, P., Taguchi, T., Thompson, J. (2009), Basics of Oncology. Germany: Springer-Verlag.
  • Morton, D., Cochran, A., Thompson, J., Sondak, V. (2009), The sentinel lymph node and regional melanoma micrometastases. In: Cutaneous Melanoma. (pp.373-386).United States: Quality Medical.
  • Gershenwald, J., Balch, C., Soong, S., Thompson, J. (2009), Prognostic Factors and Natural History of Melanoma. In: Cutaneous Melanoma. (pp.35-64).United States: Quality Medical.
  • Sladden, M., Balch, C., Barzilai, D., Berg, D., Freiman, A., Handiside, T., Hollis, S., Lens, M., Thompson, J. (2009), Surgical excision margins for primary cutaneous melanoma. Cochrane Database of Systematic Reviews. 0(4), CD004835. [Abstract]
  • Thompson, J., Morton, D., Balch, C., Ross, M. (2009), Surgical excision of distant melanoma metastases. In: Cutaneous Melanoma. (pp.603-627).United States: Quality Medical.
  • Masters, K., Wong, S., Tyler, D., Balch, C., Thompson, J. (2009), Axillary and epitrochlear lymph node dissection for melanoma. In: Cutaneous Melanoma. (pp.447-455).United States: Quality Medical.
  • Gershenwald, J., Thompson, J., Mozzillo, N., Balch, C. (2009), Intraoperative mapping and sentinel node technology in patients with melanoma. In: Cutaneous Melanoma. (pp.415-446).United States: Quality Medical.
  • Uren, R., Thompson, J., Coventry, B., Chatterton, B. (2009), Lymphoscintigraphy in patients with melanoma. In: Cutaneous Melanoma. (pp.387-413).United States: Quality Medical.
  • Beasley, G., Kroon, H., Ross, M., Kam, P., Thompson, J., Tyler, D. (2009), Isolated limb intrusion for melanoma. In: Cutaneous Melanoma. (pp.541-560).United States: Quality Medical.
  • Sober, A., Shaw, H., Thompson, J. (2009), Introduction: A history of melanoma. In: Cutaneous Melanoma. (pp.1-14).United States: Quality Medical.

2008

   
  • Thompson, J., Hersey, P., Wachter, E. (2008), Chemoablation of metastatic melanoma using intralesional Rose Bengal. Melanoma research. 18(6), 405-11. [Abstract]
  • Chen, J., Hruby, G., Scolyer, R., Murali, R., Hong, A., Fitzgerald, P., Pham, T., Quinn, M., Thompson, J. (2008), Desmoplastic neurotropic melanoma: a clinicopathologic analysis of 128 cases. Cancer. 113(10), 2770-8. [Abstract]
  • Gallagher, S., Thompson, J., Indsto, J., Scurr, L., Lett, M., Gao, B., Dunleavey, R., Mann, G., Kefford, R., Rizos, H. (2008), p16INK4a expression and absence of activated B-RAF are independent predictors of chemosensitivity in melanoma tumors. Neoplasia. 10(11), 1231-1239. [Abstract]
  • Murali, R., Loughman, N., McKenzie, P., Watson, G., Thompson, J., Scolyer, R. (2008), Cytologic Features of Metastatic and Recurrent Melanoma in Patients With Primary Cutaneous Desmoplastic Melanoma. American Journal of Clinical Pathology. 130(5), 715-723. [Abstract]
  • Kroon, H., Moncrieff, M., Kam, P., Thompson, J. (2008), Outcomes Following Isolated Limb Infusion for Melanoma. A 14-Year Experience. Annals of surgical oncology. 15(11), 3003-13. [Abstract]
  • Moncrieff, M., Martin, R., O'Brien, C., Shannon, K., Clark, J., Gao, K., McCarthy, W., Thompson, J. (2008), Adjuvant postoperative radiotherapy to the cervical lymph nodes in cutaneous melanoma: is there any benefit for high-risk patients?. Annals of Surgical Oncology. 15(11), 3022-3027. [Abstract]
  • Francken, A., Accortt, N., Shaw, H., Colman, M., Wiener, M., Soong, S., Hoekstra, H., Thompson, J. (2008), Follow-up schedules after treatment for malignant melanoma. The British journal of surgery. 95(11), 1401-7. [Abstract]
  • Moncrieff, M., Kroon, H., Kam, P., Stalley, P., Scolyer, R., Thompson, J. (2008), Isolated Limb Infusion for Advanced Soft Tissue Sarcoma of the Extremity. Annals of surgical oncology. 15(10), 2749-56. [Abstract]
  • Moncrieff, M., Scolyer, R., Thompson, J., Beavis, A., Uren, R., Stretch, J. (2008), Correct identification of a sentinel node postselective lymphadenectomy using antimony levels. Melanoma Research. 18(5), 365-366. [Abstract]
  • Kam, P., Thompson, J. (2008), Pharmacokinetics of regional therapy: isolated limb infusion and other low flow techniques for extremity melanoma. Surgical Oncology Clinics of North America. 17(4), 795-804. [Abstract]
  • Moncrieff, M., Bowen, F., Thompson, J., Saw, R., Shannon, K., Spillane, A., Quinn, M., Stretch, J. (2008), Keystone Flap Reconstruction of Primary Melanoma Excision Defects of the Leg-The End of the Skin Graft?. Annals of Surgical Oncology. 15(10), 2867-2873. [Abstract]
  • Ho Shon, I., Chung, D., Saw, R., Thompson, J. (2008), Imaging in cutaneous melanoma. Nuclear Medicine Communications. 29(10), 847-876. [Abstract]
  • Ho Shon, I., Chung, D., Saw, R., Thompson, J. (2008), Guidelines for imaging in cutaneous melanoma. Nuclear Medicine Communications. 29(10), 877-879. [Abstract]
  • Shaw, H., Scolyer, R., Thompson, J. (2008), Prognostic significance of histopathological parameters in sentinel nodes of melanoma patients. Histopathology. , 345. [Abstract]
  • Van Es, S., Colman, M., Thompson, J., McCarthy, S., Scolyer, R. (2008), Angiotropism is an Independent Predictor of Local Recurrence and In-transit Metastasis in Primary Cutaneous Melanoma. The American journal of surgical pathology. 32(9), 1396-403. [Abstract]
  • Scolyer, R., Murali, R., Satzger, I., Thompson, J. (2008), The detection and significance of melanoma micrometastases in sentinel nodes. Surgical oncology. 17(3), 165-74. [Abstract]
  • Warner, R., Quinn, M., Hruby, G., Scolyer, R., Uren, R., Thompson, J. (2008), Management of Merkel Cell Carcinoma: The Roles of Lymphoscintigraphy, Sentinel Lymph Node Biopsy and Adjuvant Radiotherapy. Annals of surgical oncology. 15(9), 2509-18. [Abstract]
  • Morton, D., Cochran, A., Thompson, J. (2008), The rationale for sentinel-node biopsy in primary melanoma. Nature clinical practice. Oncology. 5(9), 510-511. [Abstract]
  • Murali, R., Thompson, J., Scolyer, R. (2008), Sentinel lymph node biopsy for melanoma: aspects of pathologic assessment. Future oncology. 4(4), 535-551. [Abstract]
  • Spillane, A., Saw, R., Tucker, M., Byth, K., Thompson, J. (2008), Defining lower limb lymphedema after inguinal or ilio-inguinal dissection in patients with melanoma using classification and regression tree analysis. Annals of surgery. 248(2), 286-293. [Abstract]
  • Murali, R., Thompson, J., Shaw, H., Scolyer, R. (2008), The Prognostic Significance of Isolated Immunohistochemically Positive Cells in Sentinel Lymph Nodes of Melanoma Patients. The American journal of surgical pathology. , 1106-7; author reply 1107-8. [Abstract]
  • Karim, R., Scolyer, R., Li, W., Yee, V., McKinnon, J., Li, L., Uren, R., Lam, S., Beavis, A., Dawson, M., Doble, P., Hoon, D., Thompson, J. (2008), False Negative Sentinel Lymph Node Biopsies in Melanoma May Result From Deficiencies in Nuclear Medicine, Surgery, or Pathology. Annals of surgery. 247(6), 1003-1010. [Abstract]
  • Collinson, F., Lam, T., Bruijn, W., de Wilt, J., Lamont, M., Thompson, J., Kefford, R. (2008), Long-term survival and occasional regression of distant melanoma metastases after adrenal metastasectomy. Annals of Surgical Oncology. 15(6), 1741-1749. [Abstract]
  • Francken, A., Shaw, H., Thompson, J. (2008), Detection of second primary cutaneous melanomas. European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology. 34(0), 587-92. [Abstract]
  • Scolyer, R., Murali, R., McCarthy, S., Thompson, J. (2008), Pathologic examination of sentinel lymph nodes from melanoma patients. Seminars in Diagnostic Pathology. 25(2), 100-111. [Abstract]
  • Francken, A., Accortt, N., Shaw, H., Wiener, M., Soong, S., Hoekstra, H., Thompson, J. (2008), Prognosis and determinants of outcome following locoregional or distant recurrence in patients with cutaneous melanoma. Annals of surgical oncology. 15(5), 1476-1484. [Abstract]
  • Thompson, J., Kam, P. (2008), Current status of isolated limb infusion with mild hyperthermia for melanoma. International Journal of Hyperthermia. 24(3), 219-225. [Abstract]
  • Cochran, A., Thompson, J. (2008), Lymphatic mapping and sentinel node biopsy: the data unclouded by speculation. Archives of dermatology. , 687-8; author reply 688-9. [Abstract]
  • Thompson, J. (2008), The value of sentinel node biopsy in patients with primary cutaneous melanoma. Dermatologic Surgery. 34(4), 550-4; discussion 554-5. [Abstract]
  • Moncrieff, M., Shannon, K., Hong, A., Hersey, P., Thompson, J. (2008), Dramatic reduction of chronic lymphoedema of the lower limb with sorafenib therapy. Melanoma Research. 18(2), 161-162. [Abstract]
  • Francken, A., Thompson, J., Bastiaannet, E., Hoekstra, H. (2008), [Detection of the first recurrence in patients with melanoma: three quarters by the patient, one quarter during outpatient follow-up]. Nederlands tijdschrift voor geneeskunde. 152(10), 557-562. [Abstract]
  • Beavis, A., Dawson, M., Doble, P., Scolyer, R., Bourne, R., Li, L., Murali, R., Stretch, J., Lean, C., Uren, R., Thompson, J. (2008), Confirmation of Sentinel Lymph Node Identity by Analysis of Fine-Needle Biopsy Samples Using Inductively Coupled Plasma-Mass Spectrometry. Annals of surgical oncology. 15(3), 934-40. [Abstract]
  • Sassen, S., Shaw, H., Colman, M., Scolyer, R., Thompson, J. (2008), The Complex Relationships Between Sentinel Node Positivity, Patient Age, and Primary Tumor Desmoplasia: Analysis of 2303 Melanoma Patients Treated at a Single Center. Annals of surgical oncology. 15(0), 630-7. [Abstract]
  • Amersi, F., Terando, A., Goto, Y., Scolyer, R., Thompson, J., Tran, A., Faries, M., Morton, D., Hoon, D. (2008), Activation of CCR9/CCL25 in cutaneous melanoma mediates preferential metastasis to the small intestine. Clinical cancer research. 14(3), 638-645. [Abstract]
  • Lui, P., Brown, A., Wu, B., Velauthen, C., Lin, M., Thompson, J., Braet, F., Dyer, W., Macdonald, P., Hayward, C., Adelstein, S., dos Remedios, C. (2008), Use of antibody microarrays in the analysis of inflammation, autoimmunity, viral infection, and cancer metastases. In: Clinical Proteomics: From Diagnosis to Therapy. (pp.571-592).United States: John Wiley & Sons.
  • Doubrovsky, A., Scolyer, R., Murali, R., McKenzie, P., Watson, G., Lee, C., McLeod, D., McCarthy, W., Uren, R., Stretch, J., Saw, R., Thompson, J. (2008), Diagnostic Accuracy of Fine Needle Biopsy for Metastatic Melanoma and Its Implications for Patient Management. Annals of surgical oncology. 15(0), 323-32. [Abstract]
  • Murali, R., Sharma, R., Thompson, J., Stretch, J., Lee, C., McCarthy, S., Scolyer, R. (2008), Sentinel Lymph Node Biopsy in Histologically Ambiguous Melanocytic Tumors With Spitzoid Features (So-Called Atypical Spitzoid Tumors). Annals of surgical oncology. 15(0), 302-9. [Abstract]
  • Murali, R., Thompson, J., Scolyer, R. (2008), Fine-needle biopsy as a diagnostic technique for metastatic melanoma. Expert Opinion on Medical Diagnostics. 2, 1-10.
  • Wiener, M., Damian, D., Thompson, J. (2008), Systemic phototoxicity following intralesional rose bengal for subcutaneous melanoma metastases. Dermatology. , 361-362. [Abstract]
  • Gershenwald, J., Uren, R., Mariani, G., Thompson, J. (2008), Sentinel lymph node biopsy in cutaneous melanoma. In: Radioguided Surgery. (pp.92-110).United States: Springer.
  • Thompson, J., Mohacsi, P. (2008), Cancer in dialysis and renal transplant patients. In: Kidney Transplantation: Principles and Practice, 6th Ed. (pp.564-577).United Kingdom: Saunders.
  • Thompson, J. (2008), Clinical Practice Guidelines for the Management of Melanoma in Australia and New Zealand. Australia: Cancer Council Australia.
  • Karim, R., van den Berg, K., Colman, M., McCarthy, S., Thompson, J., Scolyer, R. (2008), The advantage of using a synoptic pathology report format for cutaneous melanoma. Histopathology. 52(2), 130-138. [Abstract]